A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients (vol 45, 102037, 2021)

• Tipo: Outras Publicações
• Data: 2021

Autores

Deus, CM (Autor) Outra; Pereira, SP (Autor) Outra; Cunha Oliveira, T (Autor) Outra; Teixeira, J (Autor) Outra; Simoes, RF (Autor) Outra; Fernando Cagide (Autor) FCUP; Benfeito, S (Autor) Outra; Fernanda Borges (Autor) FCUP; Raimundo, N (Autor) Outra; Oliveira, PJ (Autor) Outra

Outras Informações

ID Authenticus: P-00V-PY5

DOI: 10.1016/j.redox.2021.102117

Abstract (EN): 2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.

Idioma: Inglês

Tipo (Avaliação Docente): Científica